SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-059477
Filing Date
2024-05-14
Accepted
2024-05-14 16:00:15
Documents
11
Period of Report
2024-05-13
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 8-K evok-20240513.htm   iXBRL 8-K 40295
  Complete submission text file 0000950170-24-059477.txt   150949

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT evok-20240513.xsd EX-101.SCH 23902
14 EXTRACTED XBRL INSTANCE DOCUMENT evok-20240513_htm.xml XML 4534
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36075 | Film No.: 24944022
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)